Senseonics launches the Eversense Bridge Program in the U.S.
The company's implantable system is the only long-term CGM that lasts up to 90 days; it is now available for $99 plus the cost of the sensor placement.
Diseases & Conditions
23andMe adds type 2 diabetes screening to its Health & Ancestry test
The diabetes risk was calculated from the analysis of data 23andMe collected from more than 2.5 million customers who opted in to its research.
Propeller Health, Orion to bring new digital medicines to people with asthma and COPD
Under the deal, Orion's existing line of Easyhaler products will connect to Propeller's digital medicine platform via a small, custom-built sensor.
Microsoft patents a wearable device that could help people with Parkinson’s
The filing describes a device with an array of sensors that would be able to reduce or stabilize involuntary movement in an adjacent joint or entire limb.
Sandoz, Pear Therapeutics launch reSET to treat SUD patients
Adding reSET to outpatient therapy significantly improved abstinence in substances of abuse and treatment retention compared to standard of care alone.
An AI system may be able to identify early Alzheimer’s 6 years before clinical diagnosis
It is a work of the researchers at the University of California at Berkeley's Radiology & Biomedical Imaging Department and the Big Data in Radiology group.
LifeScan adds even more insight to its popular diabetes management app
The OneTouch Reveal mobile app can now spot recurring high or low patterns and automatically notify users so they can take action to avoid them in the future.
Livongo’s Applied Health Signals aims to reinvent the chronic-condition experience
The engine at the heart of this category is four pillars called AI+AI, which is the acronym for Aggregate, Interpret, Apply, and Iterate.
UK’s NHS Digital launches Mental Health Data Hub
The hub enables healthcare workers, patients, carers, charities and researchers to find the information most relevant to them at their fingertips.
Tencent, Medopad team-up to improve Parkinson’s disease treatment with AI
The two companies are working with the Parkinson's Center of Excellence at King's College Hospital in London to develop a software that can detect signs of Parkinson's within minutes.